Abstract
Interaction between prulifloxacin (PUFX) and pepsin was studied under a simulated physiological condition using fluorescence spectrophotometric techniques when the Eu(III) exists. The fluorescence emission intensity of pepsin was strongly quenched by the addition of prulifloxacin. Spectrophotometric observations are rationalized in terms of a static quenching process. The binding constants and the number of binding sites have been evaluated by the data obtained from the fluorescence quenching experiments. According to the vant Hoff equation, the standard enthalpy change (ΔH°) and standard entropy change (ΔS°) for the reaction were calculated and it indicated that the hydrophobic interactions play a main role in the binding of PUFX and pepsin. In addition, the binding distance R between pepsin (donor) and PUFX (acceptor) was obtained on the basis of the Forsters resonance energy transfer theory. The results obtained herein show that the interaction between the pepsin and PUFX was not influenced by Eu(III).
Keywords: PUFX, Pepsin, Fluorescence quenching, Binding constant, Eu(III), Binding Interaction, Spectroscopic Analysis, van, ’, t Hoff equation, Standard enthalpy change, Standard entropy change, Förster, s resonance energy transfer theory
Current Analytical Chemistry
Title: Analysis of Binding Interaction Between Prulifloxacin and Pepsin in the Existence of Eu(III): A Spectroscopic Analysis
Volume: 7 Issue: 3
Author(s): Xiaoyan Gao, Xiaojie Zhang, Yingcai Tang, Xiaoping Zhang, Wujie Zhao and Yanqin Zi
Affiliation:
Keywords: PUFX, Pepsin, Fluorescence quenching, Binding constant, Eu(III), Binding Interaction, Spectroscopic Analysis, van, ’, t Hoff equation, Standard enthalpy change, Standard entropy change, Förster, s resonance energy transfer theory
Abstract: Interaction between prulifloxacin (PUFX) and pepsin was studied under a simulated physiological condition using fluorescence spectrophotometric techniques when the Eu(III) exists. The fluorescence emission intensity of pepsin was strongly quenched by the addition of prulifloxacin. Spectrophotometric observations are rationalized in terms of a static quenching process. The binding constants and the number of binding sites have been evaluated by the data obtained from the fluorescence quenching experiments. According to the vant Hoff equation, the standard enthalpy change (ΔH°) and standard entropy change (ΔS°) for the reaction were calculated and it indicated that the hydrophobic interactions play a main role in the binding of PUFX and pepsin. In addition, the binding distance R between pepsin (donor) and PUFX (acceptor) was obtained on the basis of the Forsters resonance energy transfer theory. The results obtained herein show that the interaction between the pepsin and PUFX was not influenced by Eu(III).
Export Options
About this article
Cite this article as:
Gao Xiaoyan, Zhang Xiaojie, Tang Yingcai, Zhang Xiaoping, Zhao Wujie and Zi Yanqin, Analysis of Binding Interaction Between Prulifloxacin and Pepsin in the Existence of Eu(III): A Spectroscopic Analysis, Current Analytical Chemistry 2011; 7 (3) . https://dx.doi.org/10.2174/1573411011107030194
DOI https://dx.doi.org/10.2174/1573411011107030194 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Patent Selections
Recent Patents on Cardiovascular Drug Discovery Preface
Current Drug Therapy Efficacy of High-Dose Vitamin D Supplementation in the Critically Ill Patients
Inflammation & Allergy - Drug Targets (Discontinued) In-silico Evidences of Regulatory Roles of WT1 Transcription Factor Binding Sites on the Intervening Sequences of the Human Bcl-2 Gene
Current Bioinformatics Simultaneous Determination of Alogliptin and Pioglitazone in Human Plasma by a Novel LC-MS/MS Method
Current Pharmaceutical Analysis Vascular Oxidative Stress and Mitochondrial Failure in the Pathobiology of Alzheimer’s Disease: A New Approach to Therapy
CNS & Neurological Disorders - Drug Targets Protein Degradation by the Ubiquitin-Proteasome Pathway and Organ Fibrosis
Current Medicinal Chemistry Thyroid Hormone Levels in the Prefrontal Cortex of Post-Mortem Brains of Alzheimers Disease Patients
Current Aging Science Polyunsaturated Fatty Acids in Pregnancy and Metabolic Syndrome: A Review
Current Pharmaceutical Biotechnology Procalcitonin as a Biomarker for Diabetic Foot Ulcer
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Reduction of Sympathetic Hyperactivity by Agents that Inhibit the Renin Angiotensin Aldosterone System
Current Hypertension Reviews The Contrast Sensitivity Test in Early Detection of Ocular Changes in the Relation to the Type I Diabetes Mellitus Compensation in Children,Teenagers, and Young Adults
Recent Patents on Inflammation & Allergy Drug Discovery Insulin-Like Growth Factor-I Molecular Pathways in Osteoblasts: Potential Targets for Pharmacological Manipulation
Current Molecular Pharmacology Dietary Phytonutrients in the Prevention of Diabetes-related Complications
Current Diabetes Reviews Controlled Release of Protein from Hydrocolloid Gel Microbeads Before and After Drying
Current Drug Delivery Genetic Basis of Renal Mass in Rat Models
Current Hypertension Reviews Alpha 1 Anti-Trypsin: One Protein, Many Functions
Current Molecular Medicine Placental Growth Hormone, Fetal Growth and the IGF Axis in Normal and Diabetic Pregnancy
Current Diabetes Reviews Presenilin and γ -Secretase Activity: A Viable Therapeutic Target for Alzheimers Disease?
Current Signal Transduction Therapy Pharmacologic Therapy for Cardiovascular Risk Reduction in Patients with the Metabolic Syndrome
Current Pharmaceutical Design